Hereditary Renal Cancer Syndromes

Advances in Anatomic Pathology 2026

View at publisher
Authors: Kristine M. Cornejo, Miranda E. Machacek, Zhichun Lu, Letícia Campos Clemente, Xiaoyang Liu, Varsha Nair, Chin-Lee Wu
DOI: 10.1097/pap.0000000000000521
Cited by: 1
References: 171

Abstract

Hereditary renal cancer syndromes account for approximately 5% to 8% of all renal cell carcinomas (RCCs) and are caused by germline alterations, mainly in tumor suppressor genes. Advances in molecular testing have led to the identification of new hereditary syndromes and expanded our understanding of the genetic landscape of renal neoplasia. This review summarizes both well-established and recently described hereditary renal cancer syndromes, highlighting their clinical, pathologic, and molecular features. Emphases are placed on genotype-phenotype correlations and the relationship between germline and somatic alterations in tumors. Understanding these correlations is critical for diagnosis, risk assessment, surveillance, and management and underscores the importance of a high index of clinical suspicion for early detection to optimize patient outcomes.

Fields of Study & Subjects

Renal cell carcinoma treatment Genetic and Kidney Cyst Diseases Renal and related cancers

Publication details

Journal / source
Advances in Anatomic Pathology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
33
Issue
2
Pages
140–154
Publication date
2 February 2026
Language
EN